4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Virobay Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing VBY-036 - Healthy | Phase 1 | Completed | Virobay Inc. | 40 | 2013-07-01 | 2013-12-31 |
| Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A) VBY-036, Placebo - Healthy | Phase 1 | Completed | Virobay Inc. | 48 | 2013-05-01 | 2013-12-31 |
| Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1) VBY-891, Placebo - Healthy | Phase 1 | Completed | Virobay Inc. | 89 | 2013-03-01 | 2013-12-31 |
| Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults VBY 376 - Chronic Hepatitis C Infection | Phase 1 | Completed | Virobay Inc. | 48 | 2007-11-01 | 2013-12-31 |
United States (4)
David B. Karpf, MD (3) · Stephen D Flach, MD (1)